GlassScriptPhysician profile
Maddison Bell
NPI 1952009466
$1,014.52
in general payments reported to CMS, 2019-2025
15 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $549 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $222.48 | 2024-2025 | |
| Corium, LLC | $160.63 | 2024-2025 | Azstarys |
| Lundbeck LLC | $107.77 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $102.33 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $73.22 | 2024-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $69.21 | 2024-2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $67.91 | 2024-2025 | Qelbree |
| Neurocrine Biosciences, INC. | $59.64 | 2024-2025 | Ingrezza |
| Xeris Pharmaceuticals, INC. | $43.45 | 2025 | Gvoke Hypopen, Recorlev |
| Teva Pharmaceuticals USA, INC. | $28.32 | 2024 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $19.17 | 2024 | Spravato |
| Alkermes, INC. | $16.24 | 2025 | Aristada, Lybalvi |
| Bayer Healthcare Pharmaceuticals INC. | $15.95 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.46 | 2025 | Caplyta |
| Tris Pharma INC | $13.74 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maddison Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.